It's funny ALB trying to protect shareholders from "future risks" with their "attractive cash offer". Our biggest shareholders from within, who know intimately know the risks, have given that a big thumbs down.
Yes things can absolutely go wrong, but this (in my opinion) is another big vote of confidence from all involved at LTR that we're progressing nicely.
- Forums
- ASX - By Stock
- LTR
- Ann: Liontown rejects Indicative Proposal from Albemarle
Ann: Liontown rejects Indicative Proposal from Albemarle, page-671
Featured News
Add LTR (ASX) to my watchlist
(20min delay)
|
|||||
Last
86.0¢ |
Change
-0.015(1.71%) |
Mkt cap ! $2.037B |
Open | High | Low | Value | Volume |
85.0¢ | 87.0¢ | 83.5¢ | $7.128M | 8.393M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
17 | 76724 | 85.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
86.0¢ | 280701 | 22 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 50253 | 0.855 |
16 | 225896 | 0.850 |
13 | 288814 | 0.845 |
13 | 377437 | 0.840 |
11 | 870335 | 0.835 |
Price($) | Vol. | No. |
---|---|---|
0.860 | 301820 | 20 |
0.865 | 186222 | 16 |
0.870 | 440310 | 15 |
0.875 | 128792 | 4 |
0.880 | 432009 | 12 |
Last trade - 13.45pm 13/11/2024 (20 minute delay) ? |
Featured News
LTR (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online